SCHEMBL10107414

SCHEMBL10107414

CC(C)CN(Cc1cc(Cl)c2c(c1)CCCCO2)C(=O)C(C)CNCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PROKR2 Q8NFJ6 5/20 0.55
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
PTGES O14684 3/20 0.33
ALDH1A1 P00352 2/20 0.33
OPRM1 P35372 1/20 0.32
OPRK1 P41145 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
PLA2G1B P04054 1/20 0.31
POLB P06746 1/20 0.31
ATG4B Q9Y4P1 1/20 0.31
DRD2 P14416 3/20 0.31
DRD4 P21917 3/20 0.31
DRD3 P35462 3/20 0.31
MEN1 O00255 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL565014 0.92 PROKR2 (0.50) PROKR2ALDH1A1DRD2DRD4DRD3
SCHEMBL565109 0.88 PROKR2 (0.69) PROKR2PTGESALDH1A1HDAC1MEN1
SCHEMBL15693909 0.88 PROKR2 (0.69) PROKR2PTGESALDH1A1HDAC1MEN1
SCHEMBL565524 0.88 PROKR2 (0.69) PROKR2PTGESALDH1A1HDAC1MEN1
SCHEMBL10107480 0.87 PROKR2 (0.58) PROKR2MEN1KMT2A
SCHEMBL565013 0.87 PROKR2 (0.44) PROKR2ALDH1A1OPRM1OPRK1HDAC1
SCHEMBL565087 0.87 PROKR2 (0.65) PROKR2ALDH1A1HDAC1POLBMEN1
SCHEMBL565739 0.86 PROKR2 (0.55) PROKR2ALDH1A1HDAC1HDAC6DRD2
SCHEMBL10107483 0.86 PROKR2 (0.54) PROKR2ALDH1A1MEN1HTTKMT2A
SCHEMBL565461 0.84 PROKR2 (0.59) PROKR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof PROKR2, PROKR1, GIPR PROKR2 1/4885CNR1 1122/4885CNR2 525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.